Publications by authors named "Bruce Riser"

Claim this Profile
T
The role of yes activated protein (YAP) in melanoma metastasis.
Andrew Leask, John Nguyen, Angha Naik, Pratyusha Chitturi, Bruce L Riser

iScience· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the Bleomycin-Induced Model of Fibrosis to Study the Contribution of CCN Proteins to Scleroderma Fibrosis.
Alexander Peidl, John Nguyen, Pratyusha Chitturi, Bruce L Riser, Andrew Leask

Methods Mol Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy.
Andrea Resovi, Patrizia Borsotti, Tommaso Ceruti, Alice Passoni, Massimo Zucchetti, Bruce L Riser

Cells· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease?
Ellen Neven, Britt Opdebeeck, Annelies De Maré, Rida Bashir-Dar, Geert Dams, Bruce L Riser

Calcif Tissue Int· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer.
Bruce L Riser, Jeffrey L Barnes, James Varani

J Cell Commun Signal· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal delivery of sodium pyrophosphate blocks the progression of pre-existing vascular calcification in uremic apolipoprotein-E knockout mice.
Rodrigo B de Oliveira, Loïc Louvet, Bruce L Riser, Fellype C Barreto, Joyce Benchitrit

Calcif Tissue Int· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor.
Alferso C Abrahams, Sayed M Habib, Amélie Dendooven, Bruce L Riser, Jan Willem van der Veer

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of pyrophosphate delivery in a peritoneal dialysis solution on bone tissue of apolipoprotein-E knockout mice with chronic kidney disease.
Fellype C Barreto, Rodrigo B de Oliveira, Joyce Benchitrit, Loïc Louvet, Raja Rezg, Bruce L Riser

J Bone Miner Metab· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathy.
Bruce L Riser, Feridoon Najmabadi, Kendra Garchow, Jeffrey L Barnes, Darryl R Peterson

Am J Pathol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
Tatiana Tsoutsman, Xiaoyu Wang, Kendra Garchow, Bruce Riser, Stephen Twigg

J Mol Cell Cardiol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis.
Bruce L Riser, Narasimharao Bhagavathula, Patricia Perone, Kendra Garchow, Yiru Xu

J Cell Commun Signal· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia.
Bruce L Riser, Fellype Carvalho Barreto, Raja Rezg, Paul W Valaitis, Chyung S Cook

Nephrol Dial Transplant· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients.
Mario Cozzolino, Maria Luisa Biondi, Elena Banfi, Bruce L Riser, Florjan Mehmeti

Blood Purif· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with pyrophosphate inhibits uremic vascular calcification.
W Charles O'Neill, Koba A Lomashvili, Hartmut H Malluche, Marie-Claude Faugere, Bruce L Riser

Kidney Int· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.
Bruce L Riser, Feridoon Najmabadi, Bernard Perbal, Jo Ann Rambow, Melisa L Riser, Sarah C Riser

J Cell Commun Signal· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
Frederick W K Tam, Bruce L Riser, Karim Meeran, JoAnn Rambow, Charles D Pusey

Cytokine· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Bruce L Riser, Feridoon Najmabadi, Bernard Perbal, Darryl R Peterson, Jo Ann Rambow, Melisa L Riser, Sarah C Riser

Am J Pathol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: a role for CCN2 and low concentration of TGF-beta1.
Valérie Haydont, Bruce L Riser, Jocelyne Aigueperse, Marie-Catherine Vozenin-Brotons

Am J Physiol Cell Physiol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis.
Laurinda A Cooker, Darryl Peterson, Joann Rambow, Melisa L Riser, Rebecca E Riser, Bruce L Riser

Am J Physiol Renal Physiol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report.
Bruce L Riser, Pedro Cortes, Mark DeNichilo, Poornima V Deshmukh, Parminder S Chahal

Kidney Int· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria?
Sharon G Adler, Shin-Wook Kang, Stella Feld, Dae Ryong Cha, Lilly Barba, Bruce L Riser

Am J Kidney Dis· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putative subunits of the rat mesangial KATP: a type 2B sulfonylurea receptor and an inwardly rectifying K+ channel.
Balázs Szamosfalvi, Pedro Cortes, Rebecca Alviani, Kenichiro Asano, Bruce L Riser

Kidney Int· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Bruce L Riser, Mark Denichilo, Pedro Cortes, Cathryn Baker, Janet M Grondin

J Am Soc Nephrol· January 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis